Matches in Wikidata for { <http://www.wikidata.org/entity/Q37580443> ?p ?o ?g. }
- Q37580443 description "article científic" @default.
- Q37580443 description "article scientifique" @default.
- Q37580443 description "articolo scientifico" @default.
- Q37580443 description "artigo científico" @default.
- Q37580443 description "artículu científicu espublizáu en 2016" @default.
- Q37580443 description "bilimsel makale" @default.
- Q37580443 description "scientific article published on 27 May 2016" @default.
- Q37580443 description "vedecký článok" @default.
- Q37580443 description "vetenskaplig artikel" @default.
- Q37580443 description "videnskabelig artikel" @default.
- Q37580443 description "vědecký článek" @default.
- Q37580443 description "wetenschappelijk artikel" @default.
- Q37580443 description "wissenschaftlicher Artikel" @default.
- Q37580443 description "наукова стаття, опублікована в травні 2016" @default.
- Q37580443 description "научни чланак" @default.
- Q37580443 description "مقالة علمية نشرت في 27 مايو 2016" @default.
- Q37580443 name "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study" @default.
- Q37580443 name "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study" @default.
- Q37580443 name "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after" @default.
- Q37580443 type Item @default.
- Q37580443 label "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study" @default.
- Q37580443 label "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study" @default.
- Q37580443 label "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after" @default.
- Q37580443 prefLabel "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study" @default.
- Q37580443 prefLabel "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study" @default.
- Q37580443 prefLabel "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after" @default.
- Q37580443 P1433 Q37580443-305367E3-8FCA-40F0-AE5A-723046B9D3D5 @default.
- Q37580443 P1476 Q37580443-8088FF0F-3184-4B28-8CAE-797CB08885B9 @default.
- Q37580443 P2093 Q37580443-029DE328-EA65-4E60-8B9F-C1C3C656B091 @default.
- Q37580443 P2093 Q37580443-1BC236B2-37DD-4812-8A66-452F35FE494E @default.
- Q37580443 P2093 Q37580443-2735273A-9F6F-4B6C-A66D-D5DE3F697E19 @default.
- Q37580443 P2093 Q37580443-4358D87E-DDA3-4C53-BFA1-10758D43C85E @default.
- Q37580443 P2093 Q37580443-6286F35D-C110-499A-AE90-956128C74190 @default.
- Q37580443 P2093 Q37580443-69A95504-4A9E-40C2-9D0B-614D20C83B9E @default.
- Q37580443 P2093 Q37580443-830FB057-84BF-46F0-BA2B-01604BC2598B @default.
- Q37580443 P2093 Q37580443-909D8678-C1E1-4244-84B3-E059A8188547 @default.
- Q37580443 P2093 Q37580443-BDD588A1-F7FD-4FB8-A1CE-54F78A8F4BFE @default.
- Q37580443 P2093 Q37580443-E66F37FB-F20A-4495-83A9-C92734811C82 @default.
- Q37580443 P2093 Q37580443-EBB0286F-E874-44EB-B42E-0002C175F5B6 @default.
- Q37580443 P2860 Q37580443-07BF1B60-1FA7-4A92-8F7A-7649C7A8DB77 @default.
- Q37580443 P2860 Q37580443-0E246181-F8B8-43F8-AE0E-5F9AA48B34FF @default.
- Q37580443 P2860 Q37580443-1421558C-E7AA-418B-80E9-F9717DB3DDE1 @default.
- Q37580443 P2860 Q37580443-1AB0FC99-AD9B-4F7B-B9A2-8FA8D6025F5A @default.
- Q37580443 P2860 Q37580443-1C3196C9-3B8E-4A9C-89DB-A291B927AB39 @default.
- Q37580443 P2860 Q37580443-1DBF59F9-E902-4094-A6AE-1FE0F38EA354 @default.
- Q37580443 P2860 Q37580443-22C00FBB-0415-4E4F-A06B-49ED8EF0D0EA @default.
- Q37580443 P2860 Q37580443-27EE2451-5C7E-49BB-9FBE-6BE4C062C8AC @default.
- Q37580443 P2860 Q37580443-29538C30-373E-4908-B103-423D5CA7666D @default.
- Q37580443 P2860 Q37580443-4B0D4F97-2836-46D0-A795-D5C5BDEAB381 @default.
- Q37580443 P2860 Q37580443-50CCC824-D915-47CE-A1E2-D76A7593641B @default.
- Q37580443 P2860 Q37580443-56502DEF-6306-44FF-B439-41901CE88736 @default.
- Q37580443 P2860 Q37580443-56719B03-2843-4401-AF48-3EA98D408C18 @default.
- Q37580443 P2860 Q37580443-578E5EB2-E070-4A6A-BF4B-8D424E2108AE @default.
- Q37580443 P2860 Q37580443-599C8441-D67D-49CE-9DF4-8C34D7799FE9 @default.
- Q37580443 P2860 Q37580443-5F8B4857-1778-43BF-A2D3-5DF605EEDC18 @default.
- Q37580443 P2860 Q37580443-62D56232-167C-4695-AA1A-E3B2160FB61D @default.
- Q37580443 P2860 Q37580443-66CC2AE5-FA42-4E70-B829-C3AD2BB05FD9 @default.
- Q37580443 P2860 Q37580443-6E96F9A1-BDB7-4214-92B7-41AE2C7E9A8B @default.
- Q37580443 P2860 Q37580443-72188832-E856-4CE1-A5B3-1A31D9A8A7BE @default.
- Q37580443 P2860 Q37580443-778F5924-8733-4475-AD51-E0ACF6A2901A @default.
- Q37580443 P2860 Q37580443-81EDBDE5-03D9-40E1-BCAC-9D12F02AA509 @default.
- Q37580443 P2860 Q37580443-83E1EDF5-7ADD-405C-B61D-97F7FC8B786D @default.
- Q37580443 P2860 Q37580443-8E292B32-C552-49B3-A67E-B87CFAE6CF1A @default.
- Q37580443 P2860 Q37580443-95D50A4D-F978-4FAA-8051-7F403D3D383C @default.
- Q37580443 P2860 Q37580443-9CF5E801-86E7-4150-A3A9-578921477BDE @default.
- Q37580443 P2860 Q37580443-AB001555-7E33-4235-B70B-A54B73D04274 @default.
- Q37580443 P2860 Q37580443-ACCE7F38-308F-4A02-8C80-194304D98F39 @default.
- Q37580443 P2860 Q37580443-ADDF7B75-3241-425F-9AD5-A79ABF01BC08 @default.
- Q37580443 P2860 Q37580443-B4654A39-0003-4AC8-A677-E5EB2BC52F66 @default.
- Q37580443 P2860 Q37580443-B4CBAA8C-CCFC-4873-89C6-B2AE01839CC6 @default.
- Q37580443 P2860 Q37580443-B7DFA0AA-5E79-419F-B72F-B863A983E716 @default.
- Q37580443 P2860 Q37580443-C0E9BCD9-E0DE-47C6-AE20-8DAD805D7490 @default.
- Q37580443 P2860 Q37580443-C384B978-29C5-4B24-A964-701BB3D4312A @default.
- Q37580443 P2860 Q37580443-CC7C6A6C-7092-4F92-A892-9ACFE1D9AA1B @default.
- Q37580443 P2860 Q37580443-CF608636-B321-40F6-9DE5-BD7F2E2AB040 @default.
- Q37580443 P2860 Q37580443-D2F6C4C6-688D-4696-94E6-EE7E9FB39912 @default.
- Q37580443 P2860 Q37580443-DA5A6EA7-584D-46BC-A47C-F700033ED32D @default.
- Q37580443 P2860 Q37580443-E0774866-6DA0-474D-A4A6-77776A89D9E7 @default.
- Q37580443 P2860 Q37580443-F364C5EC-BB11-4A76-B46A-EF17ED7CD32E @default.
- Q37580443 P2860 Q37580443-FC901E1D-3B6A-4ECC-A2CC-A38D4AA026FD @default.
- Q37580443 P2860 Q37580443-FF3DCDA8-A0BF-4F5F-BF56-CF291D7E5C1F @default.
- Q37580443 P304 Q37580443-7FA6C10B-C9B2-4D6C-A604-6C8A466E99E3 @default.
- Q37580443 P31 Q37580443-2F36A59E-23F3-47F7-8397-61EAFF1C1948 @default.
- Q37580443 P356 Q37580443-2C2C59B0-4B2C-434F-908C-39FC4E08980B @default.
- Q37580443 P407 Q37580443-738F54E3-DAC5-4EDF-9307-146E35FECF92 @default.
- Q37580443 P433 Q37580443-4239BEC0-C4B8-42BB-8F06-5DB94AED6CF4 @default.
- Q37580443 P478 Q37580443-D0B99E9F-323D-4E81-BB29-689E4D8D276E @default.
- Q37580443 P577 Q37580443-A9271A26-3E71-497B-9012-48CCD0F78F68 @default.
- Q37580443 P698 Q37580443-AABB46CD-CC45-497E-86B2-E88874CE220C @default.
- Q37580443 P921 Q37580443-14191112-8940-4CE1-BFC4-80DA1DCC8BC3 @default.
- Q37580443 P921 Q37580443-CDBDACEC-1AE7-4557-AA0F-6AF9ACEFC0C9 @default.
- Q37580443 P921 Q37580443-F3597313-D29B-4478-B5CC-2E3F91308D57 @default.
- Q37580443 P932 Q37580443-8C57B89E-95BC-4BAD-BCFE-4AD59968091B @default.
- Q37580443 P356 ONCOTARGET.9331 @default.
- Q37580443 P698 27276706 @default.
- Q37580443 P1433 Q1573155 @default.
- Q37580443 P1476 "Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study" @default.
- Q37580443 P2093 "Binghe Xu" @default.
- Q37580443 P2093 "Donggeng Liu" @default.
- Q37580443 P2093 "Hong Zheng" @default.